Skip to Main Content

Paper Details

A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02.
Urol Oncol
17
2022
Author NameAffiliation
Alberto BrigantiVita-Salute San Raffaele University Department of Urology, IRCCS San Raffaele Hospital and Scientific Institute
Jeffrey S RossFoundation Medicine Inc., MA Upstate Medical University
  • 1 - 2

Datasets

Release 1.2